Skip to content

A comparative study of the effect of different epi-anesthetic modalities on the response to surgical extubation under general anesthesia

A comparative study of the effect of different epi-anesthetic modalities on the response to surgical extubation under general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071529
Enrollment
Unknown
Registered
2023-05-17
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid disease

Interventions

control group:Alkaline lidocaine
control group:Oxybuprocaine

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Subjects were informed and fully willing to cooperate with the study; (2) Age = 18 years; ASA class I-II; (3) No history of serious cardiovascular system disease and no airway hyperresponsiveness in the preoperative evaluation; (4) Patients intended to undergo elective thyroidectomy under general anesthesia;

Exclusion criteria

Exclusion criteria: (1) Patients who are participating in other clinical trials; (2) Patients with severe cardiovascular, hepatic, or renal disease, neurological disease, voice disorders, etc; (3) ASA classification ? grade III; (4) Emergency surgery; (5) The patient has a difficult airway or a history of previous maxillofacial and cervical surgery; (6) Patients with a history of chronic lung disease

Design outcomes

Primary

MeasureTime frame
Choking and coughing reaction;

Secondary

MeasureTime frame
Mean arterial pressure;Heart rate;Blood oxygen saturation;Extubation time;

Countries

China

Contacts

Public ContactTian Ayong

The First Hospital of China Medical University

tianayong@126.com+86 139 4018 2455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026